Navigation Links
Arpida Invited to Present Data on Iclaprim at Scientific Conference
Date:4/9/2008

e treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare associated pneumonia (HCAP).

In January 2008, the US FDA granted authorisation to progress oral iclaprim into a Phase II 'intravenous-to-oral' switch trial. Iclaprim could be offered not only as an intravenous therapy for hospital use in acute situations, but also as an oral formulation, allowing early patient discharge followed by outpatient treatment. This switch could be a valuable instrument in reducing healthcare costs and enhancing patient comfort.

Arpida's fourth most advanced antibiotic programme, AR-709, targets upper and lower respiratory tract infections acquired in the community setting. AR-709 exhibited potent activity against a large panel of pneumococcal clinical isolates including those resistant to currently used drugs. Promising results of "first-in-man" studies with AR-709 were published in March 2007.

An additional compound, AR-2474, has achieved in vivo proof of concept. AR-2474 has been shown to be effective in eradicating pathogens in preclinical models of skin infection and nasal carriage.

Apart from the antibiotic programmes, Arpida has an innovative antifungal therapy (TLT) which is in Phase III clinical trials in Europe, targeting onychomycosis.

Moreover, the company has several other leads in optimisation and additional discovery programmes derived from its own discovery platform at various research stages.

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of thes
'/>"/>

SOURCE Arpida Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Women Invited to Join New Health Registry to Advance Research
2. Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014  World Hemp Oil, ... low THC, announces they are now offering legal, organic ... Charlotte,s Web type strains grown in medical marijuana states. ... neurological disorders, such as Parkinson,s, MS, and spinal cord ... laws to pass, because imported CBD Oil Is legal ...
(Date:11/21/2014)... MONTREAL , 21. November 2014 ... hat heute bekannt gegeben, dass ... – EMA) die Kennzeichnung als Orphan-Medizinprodukt ... Produktkandidat des Unternehmens zur Behandlung von ... eine seltene, stark beeinträchtigende genetische Krankheit, ...
(Date:11/21/2014)... -- Market research firm Kalorama information says that 2014 will ... the medical device industry.  The firm thinks the $360 ... 3% growth this year, which led firms to look ... and entrance by acquisition into new competitive zones.  The ... The Global Market for Medical Devices, 5 th ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
(Date:11/22/2014)... 23, 2014 Today, Dylan Queen, a ... collection of wedding dresses; the business offers a wide ... accessories for ladies worldwide, allowing them to create multiple ... the company, this new collection of chic wedding dresses ... they are offered at discounted rates now. Dylan Queen ...
(Date:11/22/2014)... Discount-Dress.com is an important company ... is to increase the company’s online market share by a ... of bridesmaid dresses and announced a bridesmaid dress promotion for ... Dec. 30, 2014. All the dresses from this company are ... In fact, Discount-Dress.com is very good at manufacturing wedding dresses. ...
(Date:11/22/2014)... November 22, 2014 "My friend went ... caused by the machine," said an inventor from Cambria ... to go back a second time because the first ... , She developed the patent-pending MAMO EASY to offer ... The design saves the patient from the pain normally ...
(Date:11/22/2014)... The wide variety and complexity of foods served at ... food allergies, an expert warns. "Every person is ... allergies that it can be really difficult to avoid ... of allergy and clinical immunology at Wake Forest Baptist ... "If you know you have food allergies, caution should ...
(Date:11/22/2014)... month has been a historical time for Angeldress.co.uk, an excellent ... from some renowned review websites. Recently, the company has added ... selection of wonderful sexy wedding dresses to its website. At ... up to an 80% discount on any order over GBP ... suitable dress at Angeldress.co.uk, which has garnered a hard core ...
Breaking Medicine News(10 mins):Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2
... , , DENVER, Sept. 15 ... of kidney care services for those diagnosed with chronic kidney disease ... the End Stage Renal Disease (ESRD) Network,s patient quality improvement goal. ... in Virginia by promoting increased use of fistulas, thereby minimizing the ...
... found 138 sites that sold them illegally, without a prescription ... on their own that they need antibiotics can easily find ... benefit of a prescription, new research shows. , The practice ... an overuse of antibiotics that is known to create resistant ...
... , , , , ... ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products, ... Life Sciences Conference at the Grand Hyatt Hotel in New York. ... at 4:30 p.m. Eastern Time on Tuesday, September 22, 2009. , ...
... , , , PROVIDENCE, ... are invited to step forward on October 4, 2009 at ... "The Walk: Hasbro Children,s Hospital." Patients, families, hospital staff ... money to support patient care and cutting-edge pediatric research in ...
... , , , ... Inc. (Pink Sheets: ASFX) (the Company) today announced the appointment ... as Senior Vice President and Director of Business Development of ... of the intellectual property formerly owned by Safeguard, which produces ...
... , , , WASHINGTON, Sept. ... a forum held by the House Democratic Steering and Policy Committee ... are the Speaker,s remarks: , , "Good morning. ... we are closer than ever before in history to passing health ...
Cached Medicine News:Health News:New Data Shows DaVita Facilities Lead Virginia in Improving Kidney Patient Care 2Health News:Antibiotics Bought Easily on the Internet 2Health News:Antibiotics Bought Easily on the Internet 3Health News:ATS Medical to Participate at the 2009 UBS Global Life Sciences Conference 2Health News:Hasbro Children's Hospital Kicks Off Inaugural Fundraising Walk 2Health News:Hasbro Children's Hospital Kicks Off Inaugural Fundraising Walk 3Health News:American Scientific Resources, Inc. Welcomes Jason Roth 2Health News:Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 2Health News:Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 3
... has been developing diverse medical ... years. Our medical-surgical products have ... innovation, quality and customer satisfaction. ... the Labtron® line of diagnostic ...
... Nebulizers deliver particulate humidity in the 3 ... secretion patients. For your convenience, Thera-Mist® nebulizers ... of sterile water., ,The P30000N, for ... 20-50% with a total flow range of ...
... can be held at angles up to 45° ... in spill column, finger grooves for a non-slip ... 7 feet of regular oxygen tubing. The ... size and sustain optimum mist concentration at every ...
With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
Medicine Products: